Evidence map›Paper›PMID 28376121›Full record

ArticlePLoS genetics2017

The time and place of European admixture in Ashkenazi Jewish history.

James Xue, Todd Lencz, Ariel Darvasi, Itsik Pe'er, Shai Carmi

Abstract read
In one paragraph

Article in PLoS genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Lactase deficiency in Russia: multiethnic genetic study.European journal of clinical nutrition · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Revealing the recent demographic history of Europe via haplotype sharing in the UK Biobank.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Human genetic admixture through the lens of population genomics.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

James XueDepartment of Computer Science, Columbia University, New York, New York, United States of America.
Todd LenczCenter for Psychiatric Neuroscience, The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, New York, United States of America.
Ariel DarvasiDepartment of Genetics, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
Itsik Pe'erDepartment of Computer Science, Columbia University, New York, New York, United States of America.
Shai CarmiBraun School of Public Health and Community Medicine, The Hebrew University of Jerusalem, Ein Kerem, Jerusalem, Israel.ORCID 0000-0002-0188-2610

Funding

Next Generation Sequencing for Disease Mapping in a Founder PopulationR01MH095458 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI DARVASI, ARIEL, LENCZ, TODD · 2013 to 2016
$3.8M
Common and Rare Genetic Factors in an Ethnically Homogeneous Schizophrenia CohortRC2MH089964 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI LENCZ, TODD · 2009 to 2010
$3.5M
NIMH NIH HHS R01 MH095458NIMH NIH HHS RC2 MH089964
6 · The paper itself

Abstract

The Ashkenazi Jewish (AJ) population is important in genetics due to its high rate of Mendelian disorders. AJ appeared in Europe in the 10th century, and their ancestry is thought to comprise European (EU) and Middle-Eastern (ME) components. However, both the time and place of admixture are subject to debate. Here, we attempt to characterize the AJ admixture history using a careful application of new and existing methods on a large AJ sample. Our main approach was based on local ancestry inference, in which we first classified each AJ genomic segment as EU or ME, and then compared allele frequencies along the EU segments to those of different EU populations. The contribution of each EU source was also estimated using GLOBETROTTER and haplotype sharing. The time of admixture was inferred based on multiple statistics, including ME segment lengths, the total EU ancestry per chromosome, and the correlation of ancestries along the chromosome. The major source of EU ancestry in AJ was found to be Southern Europe (≈60-80% of EU ancestry), with the rest being likely Eastern European. The inferred admixture time was ≈30 generations ago, but multiple lines of evidence suggest that it represents an average over two or more events, pre- and post-dating the founder event experienced by AJ in late medieval times. The time of the pre-bottleneck admixture event, which was likely Southern European, was estimated to ≈25-50 generations ago.

Indexed as

Genetics, PopulationEuropeFemaleHaplotypesHumansJewsLinkage DisequilibriumMalePolymorphism, Single NucleotideWhite People

Identifiers

PMID28376121
PMCPMC5380316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.